ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1695

Validation of Vesmeter As a Diagnostic Tool of Scleroderma

Yoshihiro Hishitani1,2, Yoshihito Shima1, Toshio Tanaka1 and Atsushi Kumanogoh1, 1Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 2Internal Medicine, Kinki Central Hospital, Itami, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Diagnostic Tests, Evaluation, scleroderma and skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis, Diagnostic and Therapeutic Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Objective method to evaluate the skin involvement in the patients with scleroderma has not been definitely established. We have developed Vesmeter, a computer-linked device to simultaneously quantify the skin characteristics such as viscosity, elasticity and softness, and have reported its usefulness to evaluate the skin characteristics of patients with scleroderma. Here, we validated Vesmeter as a diagnostic tool of scleroderma.

Methods: Using Vesmeter, we evaluated the skin characteristics of patients with scleroderma and healthy volunteers. 17 points of the body were evaluated, like modified Rodnan’s skin score. First, we compared the skin characteristics of scleroderma patients with that of healthy volunteers matched by age and sex. Second, we conducted bivariate Receiver Operating Characteristic (ROC) analyses to examine which points and parameters are useful to diagnose scleroderma. Third, using whole data of healthy volunteers, we conducted logistic regression and ROC analysis to validate Vesmeter as a diagnostic tool of scleroderma.

Results: 39 patients with scleroderma and 413 healthy volunteers were included. Among the healthy volunteers, 78 people were selected at random, matching age and sex with patients as the control group for the first and second analyses. Regarding the background of the 2 groups, body weight of patients was lighter than controls. As the result of the comparison of skin characteristics, patients’ skin were statistically harder and showed higher elasticity than control on both fingers, left hand, both forearms (Figure 1), both lower legs, and both feet. Viscosity of patients’ skin were also statistically higher than control on both fingers, both hands, both forearms, face, chest, right femur, and right foot. As the result of bivariate ROC analyses, moderate accuracy to distinguish patients from control was recognized by softness of both fingers and both forearms, elasticity of right finger and both forearm, and viscosity of left finger, right hand, both forearms, and face. Based on this result, age, body weight, softness of both fingers and right forearm, elasticity of left forearm, and viscosity of face, left finger, right hand, and both forearms were selected variables for the next logistic regression and ROC analysis using whole data of 413 healthy volunteers. (One of softness and elasticity was used because of the multi-collinearity). This ROC analysis resulted in high accuracy (AUC = 0.92514, Sensitivity = 0.7949, Specificity = 0.9562) to diagnose scleroderma (Figure 2).

Conclusion: Vesmeter showed high accuracy to diagnose scleroderma.


Disclosure:

Y. Hishitani,
None;

Y. Shima,
None;

T. Tanaka,
None;

A. Kumanogoh,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-vesmeter-as-a-diagnostic-tool-of-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology